Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis.

Hiltunen J, Parmanne P, Sokka T, Lamberg T, Isomäki P, Kaipiainen-Seppänen O, Peltomaa R, Uutela T, Pirilä L, Taimen K, Kauppi MJ, Yli-Kerttula T, Tuompo R, Relas H, Kortelainen S, Paalanen K, Asikainen J, Ekman P, Santisteban A, Vidqvist KL, Tadesse K, Romu M, Borodina J, Elfving P, Valleala H, Leirisalo-Repo M, Rantalaiho V, Kautiainen H, Jokiranta TS, Eklund KK, FinADASpA Study Group

Open source

DOI: 10.1007/s00296-021-04955-8
Published: 2022 Jun
Container: Rheumatology international
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00296-021-04955-8,
  title = {Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis.},
  author = {Hiltunen J and Parmanne P and Sokka T and Lamberg T and Isomäki P and Kaipiainen-Seppänen O and Peltomaa R and Uutela T and Pirilä L and Taimen K and Kauppi MJ and Yli-Kerttula T and Tuompo R and Relas H and Kortelainen S and Paalanen K and Asikainen J and Ekman P and Santisteban A and Vidqvist KL and Tadesse K and Romu M and Borodina J and Elfving P and Valleala H and Leirisalo-Repo M and Rantalaiho V and Kautiainen H and Jokiranta TS and Eklund KK and FinADASpA Study Group},
  year = {2022},
  journal = {Rheumatology international},
  doi = {10.1007/s00296-021-04955-8},
  url = {https://doi.org/10.1007/s00296-021-04955-8}
}

RIS

TY  - JOUR
TI  - Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis.
AU  - Hiltunen J
AU  - Parmanne P
AU  - Sokka T
AU  - Lamberg T
AU  - Isomäki P
AU  - Kaipiainen-Seppänen O
AU  - Peltomaa R
AU  - Uutela T
AU  - Pirilä L
AU  - Taimen K
AU  - Kauppi MJ
AU  - Yli-Kerttula T
AU  - Tuompo R
AU  - Relas H
AU  - Kortelainen S
AU  - Paalanen K
AU  - Asikainen J
AU  - Ekman P
AU  - Santisteban A
AU  - Vidqvist KL
AU  - Tadesse K
AU  - Romu M
AU  - Borodina J
AU  - Elfving P
AU  - Valleala H
AU  - Leirisalo-Repo M
AU  - Rantalaiho V
AU  - Kautiainen H
AU  - Jokiranta TS
AU  - Eklund KK
AU  - FinADASpA Study Group
PY  - 2022
JO  - Rheumatology international
DO  - 10.1007/s00296-021-04955-8
UR  - https://doi.org/10.1007/s00296-021-04955-8
ER  -

APA

J, H., P, P., T, S., T, L., P, I., O, K., R, P., T, U., L, P., K, T., MJ, K., T, Y., R, T., H, R., S, K., K, P., J, A., P, E., A, S., KL, V., K, T., M, R., J, B., P, E., H, V., M, L., V, R., H, K., TS, J., KK, E., & Group, F. S. (2022). Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis.. Rheumatology international. https://doi.org/10.1007/s00296-021-04955-8

Source records

pubmed · retrieved 2026-09-26T13:10:03.407Z
europe-pmc · retrieved 2026-09-26T13:10:03.397Z